1YOKOYAMA Y, SATO S, FUTAGA M, et al. Prognostic significance of vascular endometrial growth factor and its receptors in endometrial carcinoma [ J ]. Gynecologic Oncology,2007 (77) :413 - 418.
2SHIBUYA M,CLAESSON-WELSH L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis [ J]. Experimental Cell Research,2006(312) :549 -560.
8Niculescu AB 3rd, Chen X, Smeets M. Effects of p21 (CIP1/WAF1) at both the G1/S and the G1 * 2/M cell cycle transitions : pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Molecular and Cellular Biology,1998.
9Takahashi Y, Kitadai Y, Bucana CD. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Research, 1995.
10Cazzalini O, Perucca P, Riva F. p21 CDKNIA does not interfere with loading of PCNA at DNA replication sites, but inhibitssubsequent binding of DNA polymerase delta at the G1/S phase transition. Cell Cycle,2000.
3Boccacino C,Ando M,Tamagnone L,et al.Induction of epithelial tubules by growth factor HGF depends on the STAT pathway[J].Nature,1998,391:285-288.
4Ueoka Y,Kato K,Kuriaki Y,et al.Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway[J].Br J Cancer,2000,82:891-899.
5Shinomiya N,Gao CH,Xie Q,et al.RNA interference reveals that ligand-independent met activity is required for tumor cell signialing and survival[J].Cancer Res,2004,64(1):7962-7970.
6Martin TA,Parr C,Davies G,et al.Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4,a HGF/SF antagonist[J].Carcinogenesis,2003,24(8):1317-1323.
7Nagy J A,Vasile E,Feng D,et al.Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis[J].J Exp Med,2002,196(11):1497-1506.
8Abulafia O,Triest W E,Sherer D M.Angiogenesis in malignancies of the female genital tract[J].Gynecol Oncol,1999,72(2):220-231.
